Health Care & Life Sciences » Pharmaceuticals | Yabao Pharmaceutical Group Co. Ltd.

Yabao Pharmaceutical Group Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,612
1,873
2,045
1,779
2,519
2,876
Cost of Goods Sold (COGS) incl. D&A
926
945
1,037
1,071
1,171
1,228
Gross Income
686
928
1,009
707
1,348
1,648
SG&A Expense
549
688
735
734
1,085
1,299
EBIT
129
228
262
23
263
344
Unusual Expense
-
1
-
2
5
-
Non Operating Income/Expense
30
9
11
61
4
18
Interest Expense
48
51
53
35
43
39
Pretax Income
130
190
248
28
225
330
Income Tax
17
25
30
1
25
46
Consolidated Net Income
113
165
218
27
200
284
Net Income
118
170
222
23
200
273
Net Income After Extraordinaries
118
170
222
23
200
273
Net Income Available to Common
118
170
222
23
200
273
EPS (Basic)
0.17
0.25
0.32
0.03
0.25
0.35
Basic Shares Outstanding
692
692
692
787
787
785
EPS (Diluted)
0.17
0.25
0.32
0.03
0.25
0.35
Diluted Shares Outstanding
692
692
692
787
787
785
EBITDA
222
354
398
130
432
515
Other Operating Expense
-
9
12
12
3
5
Non-Operating Interest Income
4
5
3
6
6
7
Minority Interest Expense
5
5
4
5
-
11

About Yabao Pharmaceutical Group Co.

View Profile
Address
11/F, Building 2, Yard 11
Beijing Beijing 100176
China
Employees -
Website http://www.yabao.com.cn
Updated 07/08/2019
Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It focuses on medicine and health business. The company's products include Chinese and western medicine preparations, raw materials, and pharmaceutical packaging materials, mainly for the elderly chronic drug and women and children medication; cardiovascular and cerebrovascular drugs, and health products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.